Shin Nippon Biomedical Laboratories, Ltd. (FRA:YB3)
Germany flag Germany · Delayed Price · Currency is EUR
8.60
+0.05 (0.58%)
Last updated: Jan 29, 2026, 8:16 AM CET

FRA:YB3 Ratios and Metrics

Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
367368387793523224
Market Cap Growth
-10.53%-4.96%-51.14%51.44%133.49%20.59%
Enterprise Value
514517472848550283
Last Close Price
8.608.808.6716.9910.964.64
PE Ratio
13.7012.1011.4318.899.917.95
PS Ratio
1.841.842.394.563.981.93
PB Ratio
1.671.491.854.343.581.84
P/TBV Ratio
1.781.571.984.673.651.88
P/FCF Ratio
29.27---16.017.91
P/OCF Ratio
7.398.4730.0128.5911.866.13
EV/Sales Ratio
2.722.582.914.884.182.44
EV/EBITDA Ratio
10.4914.9612.7617.8913.819.90
EV/EBIT Ratio
15.8428.0418.4923.3517.6814.55
EV/FCF Ratio
40.98---16.8210.00
Debt / Equity Ratio
1.000.860.770.710.460.80
Debt / EBITDA Ratio
6.376.164.342.741.703.41
Debt / FCF Ratio
17.50---2.073.45
Asset Turnover
0.390.380.400.520.470.40
Inventory Turnover
1.301.241.242.061.911.87
Quick Ratio
0.610.630.690.730.790.86
Current Ratio
1.101.131.311.141.211.24
Return on Equity (ROE)
12.29%13.10%18.24%26.26%40.30%22.82%
Return on Assets (ROA)
2.05%2.21%3.90%6.79%6.88%4.16%
Return on Invested Capital (ROIC)
3.86%4.30%7.81%14.49%17.05%9.42%
Return on Capital Employed (ROCE)
4.70%4.70%7.90%14.50%16.20%10.10%
Earnings Yield
7.30%8.27%8.75%5.29%10.09%12.58%
FCF Yield
3.42%-6.41%-10.25%-0.73%6.25%12.64%
Dividend Yield
3.47%3.51%3.53%2.04%2.03%1.66%
Payout Ratio
45.14%42.65%37.48%41.01%11.60%5.65%
Buyback Yield / Dilution
---0.00%--
Total Shareholder Return
3.47%3.51%3.53%2.04%2.03%1.66%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.